+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics



Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics



Singapore Medical Journal 57(3): 132-137



Hepatic venous pressure gradient (HVPG) measurement is recommended for prognostic and therapeutic indications in centres with adequate resources and expertise. Our study aimed to evaluate the quality of HVPG measurements at our centre before and after introduction of a standardised protocol, and the clinical relevance of the HVPG to variceal bleeding in cirrhotics. HVPG measurements performed at Singapore General Hospital from 2005-2013 were retrospectively reviewed. Criteria for quality HVPG readings were triplicate readings, absence of negative pressure values and variability of ≤ 2 mmHg. The rate of variceal bleeding was compared in cirrhotics who achieved a HVPG response to pharmacotherapy (reduction of the HVPG to < 12 mmHg or by ≥ 20% of baseline) and those who did not. 126 HVPG measurements were performed in 105 patients (mean age 54.7 ± 11.4 years; 55.2% men). 80% had liver cirrhosis and 20% had non-cirrhotic portal hypertension (NCPH). The mean overall HVPG was 13.5 ± 7.2 mmHg, with a significant difference between the cirrhosis and NCPH groups (p < 0.001). The proportion of quality readings significantly improved after the protocol was introduced. HVPG response was achieved in 28 (33.3%, n = 84) cirrhotics. Nine had variceal bleeding over a median follow-up of 29 months. The rate of variceal bleeding was significantly lower in HVPG responders compared to nonresponders (p = 0.025). The quality of HVPG measurements in our centre improved after the introduction of a standardised protocol. A HVPG response can prognosticate the risk of variceal bleeding in cirrhotics.

(PDF emailed within 1 workday: $29.90)

Accession: 057222249

Download citation: RISBibTeXText

PMID: 26996384


Related references

Measurement of hepatic venous pressure gradient in patients with active variceal bleeding. Hepatology 41(2): 406-7; Author Reply 407, 2005

Hepatic venous pressure gradient measurement before TIPS for acute variceal bleeding. World Journal of Gastroenterology 20(23): 7523-7524, 2015

A cost-effectiveness study of hepatic venous pressure gradient measurement in the secondary prevention of variceal bleeding. Revista Espanola de Enfermedades Digestivas 100(7): 416-422, 2008

Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding. Medicina 45(1): 8-13, 2009

Clinical application of hepatic venous pressure gradient to predict early bleeding after esophageal variceal ligation. Zhonghua Gan Zang Bing Za Zhi 23(1): 50-54, 2015

Hepatic Venous Pressure Gradient Measurement in Bangladeshi Cirrhotic Patients: A Correlation with Child's Status, Variceal Size, and Bleeding. Euroasian Journal of Hepato-Gastroenterology 7(2): 142-145, 2017

Hepatic venous pressure gradient in cirrhosis: role in variceal bleeding, non-bleeding complications and outcome. Asian Journal of Surgery 29(3): 113-119, 2006

Prevention of variceal bleeding and measurement of hepatic vein pressure gradient. Korean Journal of Hepatology 12(3): 464-468, 2006

Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding. Alimentary Pharmacology & Therapeutics 19(5): 571-581, 2004

The cost effectiveness of hepatic venous pressure gradient monitoring in prevention of recurrent variceal bleeding. Gastroenterology 122(4 Suppl 1): A 79, 2002

Treatment of acute variceal bleeding by the hepatic venous pressure gradient Preliminary results of a randomized trial. Hepatology 30(4 PART 2): 220A, 1999

Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 131(5): 1611-1624, 2006

Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices. Alimentary Pharmacology and Therapeutics 26(11-12): 1479-1487, 2007

Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. Journal of Hepatology 48(2): 229-236, 2007

Monitoring hepatic venous pressure gradient in patients on beta blocker therapy for primary prophylaxis of variceal bleeding is cost-effective. Gastroenterology 112(4 SUPPL ): A1355, 1997